Platelet-Mediated Inflammation in Cardiovascular Disease. Potential Role of Platelet-Endothelium Interactions

Author(s): Maria E. Tsoumani, Kallirroi I. Kalantzi, Ioannis A. Goudevenos, Alexandros D. Tselepis

Journal Name: Current Vascular Pharmacology

Volume 10 , Issue 5 , 2012

Become EABM
Become Reviewer
Call for Editor


Inflammation of the vascular wall is considered as the principal underlying mechanism in the development of atherosclerosis. Besides their specific functions in haemostasis via thrombus formation after an endothelial injury, a growing body of evidence indicates that platelets play an important role in the inflammatory reactions occurring in the vascular wall as well as in the subsequent tissue repair mechanisms. Platelets interact with activated endothelium as well as with circulating leukocytes and progenitor cells. These interactions, involve direct cell-to-cell interactions as well as autocrine and paracrine pathways, which lead to activation of platelets and their respective cellular counterpart. An increasing body of evidence suggests that antiplatelet therapy may reduce vascular inflammation primarily by inhibiting platelet activation. The aim of the present review is to highlight the molecular basis of platelet-mediated inflammatory response, focusing on the mechanisms underlying the platelet-endothelial cell interaction. The anti-inflammatory effects of current antiplatelet therapies will be also discussed.

Keywords: Atherosclerosis, cardiovascular disease, endothelium, inflammation, leukocytes, platelets, acute coronary syndromes, myocardial infarction, ischaemic stroke, peripheral artery disease

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Page: [539 - 549]
Pages: 11
DOI: 10.2174/157016112801784602
Price: $65

Article Metrics

PDF: 24